Growth hormone resistance and somatomedins in children with end-stage liver disease awaiting transplantation

Journal of Pediatric Gastroenterology and Nutrition

Volumn 27, Issue 2, 1998, Pages 148-154

  Greer, Ristan M ^a   Quirk, Paul ^a   Cleghorn, Geoffrey J ^a   Shepherd, Ross W ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Growth hormone; Liver disease; Somatomedins

Indexed keywords

BILIRUBIN; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; HUMAN GROWTH HORMONE; POTASSIUM ION; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ALAGILLE SYNDROME; ARTICLE; BILE DUCT ATRESIA; BILIRUBIN BLOOD LEVEL; BODY FAT; CHILD; CHILD NUTRITION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENERGY EXPENDITURE; FEMALE; GROWTH HORMONE RELEASE; HORMONE RESISTANCE; HUMAN; LIVER FAILURE; LIVER FUNCTION; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY QUOTIENT; SUBCUTANEOUS DRUG ADMINISTRATION; TOTAL BODY POTASSIUM;

BILIRUBIN; BODY COMPOSITION; CHILD; CHILD, PRESCHOOL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG RESISTANCE; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INFANT; LIVER; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; NUTRITIONAL STATUS; PLACEBOS; POTASSIUM; SOMATOMEDINS;

EID: 0031927745     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199808000-00004     Document Type: Article

References (39)

1. Gartner JC, Zitelli BJ, Malatack JJ et al. Orthotopic liver transplantation in children: Two-year experience with 47 patients. Pediatrics 1984;74:140-5.
2. Shepherd RW. The treatment of end stage liver disease in childhood. Aust Pediatr J 1988;24:213-6.
3. Shepherd RW, Chin S, Patrick M, et al. Malnutrition in children with chronic liver disease accepted for liver transplantation. J Pediatr Child Health 1991;27:295-9.
4. Chin SE, Shepherd RW, Cleghorn GJ, et al. Pre-operative nutritional support in children with end stage liver disease accepted for liver transplantation: An approach to management. J Gastroenterol Hepatol 1990;5:566-72.
5. Chin SE, Shepherd RW, Thomas BJ, et al. The nature of malnutrition in children with end stage liver disease awaiting orthotopic liver transplantation. Am J Clin Nutr 1992;56:164-8.
6. Chin SE, Shepherd RW, Thomas BJ, et al. Nutritional support in children with liver disease: A randomized crossover trial of branched chain amino acid supplement. Am J Clin Nutr 1992;56: 158-63.
7. Isaksson OGP, Lindahl A, Nilsson A, Isgaard J. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 1987;8:426-38.
8. Hindmarsh PC, Bridges NA & Brook CDG. Wider indications for treatment with biosynthetic human growth hormone in children. Clin Endocrinol 1991;34:417-27.
9. Isaksson OGP, Efen S, Jansson JO. Mode of action of pituitary growth hormone on target cells. Ann Rev Physiol 1985;47:482-99.
10. Moller S, Becker U. Insulin like growth factor I and growth hormone in chronic liver disease. Dig Dis 1992;10:239-48.
11. Brook CGD. Determination of body composition of children from skinfold measurements. Arch Dis Child 1971;46:182-4.
12. Moore FD, Olesen KH, McMurrey JD, Ball MR, Boyden CM. The body cell mass and its supporting environment. Philadelphia: WB Saunders, 1963.
13. Shepherd RW, Holt TE, Greer RM, Cleghorn GJ, Thomas BJ. Total body potassium in cystic fibrosis. J Pediatr Gastroenterol Nutr 1989;9:200-5.
14. Thomson M, Bucolo S, Quirk P, Shepherd RW. Measured v. predicted resting energy expenditure in infants: A need for reappraisal. J Pediatr 1995;1:21-7.
15. Thomson MA, Wilmott RW, Wainwright C, Masters B, Francis PJ, Shepherd RW. Resting energy expenditure, pulmonary inflammation and genotype in the early course of cystic fibrosis. J Pediatr 1996;129:367-73.
16. Gremse DA, A-Kader HH, Schroeder TJ, Balistreri WF. Assessment of lidocaine metabolite formation as a quantitative liver function test in children. Hepatology 1990;12:565-9.
17. Crawford DH, Shepherd RW, Halliday JW, Cooksley GW, Golding SD, Cheng WS, Powell EW. Body composition in nonalcoholic cirrhosis: The effect of disease etiology and severity on nutritional compartments. Gastroenterology 1994;106:1611-7.
18. Greer RM, Shepherd RW, Cleghorn GJ, Bowling FG, Holt TL. Evaluation of growth and changes in body composition following neonatal diagnosis of cystic fibrosis. J Pediatr Gastroenterol Nutr 1991;13:52-8.
19. Potter JM, Hickman PE, Lynch SV, et al. Use of monoethylglycinexylidide as a liver function test in the liver transplant recipient. Transplantation 1993;56:1385-8.
20. Francis GL, McNeil KA, Wallace JC, Ballard FJ, Owens PC. Sheep insulin like growth factors I and II: Sequences, activities and assays. Endocrinology 1989;124:1173-83.
21. Barnard R, Quirk P, Waters MJ. Characterization of the growth- hormone binding protein of human serum using a panel of monoclonal antibodies. J Endocrinol 1989;123:327-32.
22. Baxter RC, Martin JL., Wood MH. Two immunoreactive binding proteins for insulin like growth factors in human amniotic fluid: Relationship to fetal maturity. J Clin Endocrinol Metab 1987;65: 423-31.
23. Baxter RC, Martin JL. Radioimmunoassay of growth hormone dependent insulin like growth factor binding protein in human plasma. J Clin Invest 1986;78:1504-12.
24. Quirk P, Owens P, Moyse K, Chin S, Wall C, Ballard J, Shepherd R. Insulin-like growth factors I and II are reduced in plasma from growth retarded children with chronic liver disease. Growth Regulation 1994;4:35-8.
25. Bucuvalas JC, Horn JA, Slusher J, Alfaro MP, Chernausek SD. Growth hormone insensitivity in children with biliary atresia. J Pediatr Gastroenterol Nutr 1996;23:135-40.
26. Holly JMP, Smith CP, Dunger DB, et al. Levels of the small insulin-like growth factor binding protein are strongly related to those of insulin in prepubertal and pubertal children but only weakly so after puberty. J Endocrinol 1989;121:383-7.
27. Bucuvalas JC, Cutfield W, Horn JA, et al. Resistance to the growth-promoting and metabolic effects of growth hormone in children with chronic liver disease. J Pediatr 1990;117:397-402.
28. Clemmons DR, Underwood LE, Dickerson RN, et al. Use of plasma somatomedin-C/insulin-like growth factor I measurements to monitor the response to nutritional repletion in malnourished patients. Am J Clin Nutr 1985;41:191-8.
29. Mathews LS, Norstedt G, Palmiter RD. Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci 1986;83:9343-7.
30. Ketelslegers JM, Maiter D, Maes M, Underwood LE, Thissen JP. Nutritional regulation of insulin-like growth factor I. Metabolism 1995;44(10 Suppl 4):50-7.
31. Hynes MA, Van Wyk JJ, Brooks PJ, D'Ercole AJ, Jansen M, Lund PK. Growth hormone dependence of somatomedin-C/insulin like growth factor I and insulin like growth factor II messenger ribonucleic acids. Mol Endocrinol 1987;1:233-42.
32. Owens PC, Johnson RJ, Campbell RG, Ballard FJ. Growth hormone increases insulin-like growth factor-I (IGF-I) and decreases IGF-II in plasma of growing pigs. J Endocrinol 1990;124:269-75.
33. Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R. Growth hormone, insulin-like growth factor-I and insulin like growth factor binding proteins 1 and 3 in chronic liver disease. Hepatology 1995;21:697-702.
34. Hattori N, Kurahachi H, Ikekubo K, et al. Serum GH-binding protein, insulin-like growth factor-I, and growth hormone in patients with liver cirrhosis. Metabolism 1992;41:377-81.
35. Baruch Y, Amit T, Hertz P, Enat R, Youdim MB, Hochberg Z. Decreased serum growth hormone-binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab 1991;73:777-80.
36. Tiong TS, Herington AC. Tissue distribution, characterization and regulation of messenger ribonucleic acid for growth hormone receptor and serum binding protein in the rat. Endocrinology 1991; 129:1628-34.
37. Herington AC, Tiong TS, Ymer SI. Serum binding proteins for growth hormone: Origins, regulation of gene expression and possible roles. Acta Paediatr Scand 1991;[Suppl]379:61-9.
38. Brinkman A, Groffen C, Kortleve DJ, et al. Isolation and characterisation of a cDNA encoding the low molecular weight insulin like growth factor finding protein (IGFBP-1). EMBO J 1988;7: 2417-23.
39. Julkunen M, Koistinen R, Aalto-Setala K, et al. Primary structure of human insulin-like growth factor binding protein 12 and tissue-specific expression of its mRNA. FEBS Lett 1988;236:295-302.